ENDRA Life Sciences Inc. Appoints Alexander Tokman as Acting Chief Executive Officer and Adds Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer
Ann ArborManufacturingBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics
Description
ENDRA Life Sciences Inc. announced the appointment of Alexander Tokman as acting Chief Executive Officer to replace Francois Michelon, who stepped down from his role as Chief Executive Officer and as a member of the Board of Directors. Additionally, the Company added Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer.
Company Information
Company
ENDRA Life Sciences
Location
Ann Arbor, Michigan, United States
About
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with 400,000 cart-based ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.
Fundz sees it the moment ENDRA Life Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ann ArborManufacturingBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics